Mario Gabelli Organon & Co. Transaction History
Gamco Investors, Inc. Et Al
- $8.56 Billion
- Q2 2024
A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Organon & Co. stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 21,372 shares of OGN stock, worth $351,783. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,372
Previous 21,372
-0.0%
Holding current value
$351,783
Previous $401,000
10.22%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding OGN
# of Institutions
775Shares Held
190MCall Options Held
1.59MPut Options Held
931K-
Black Rock Inc. New York, NY32.6MShares$536 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$497 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.1MShares$166 Million0.07% of portfolio
-
State Street Corp Boston, MA9.01MShares$148 Million0.01% of portfolio
-
Nordea Investment Management Ab Stockholm, V76.74MShares$111 Million0.15% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $4.19B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...